EU Merger Control, FDI Screening and the Foreign Subsidies Regulation

Merger control under the EU Merger Regulation#

Transactions with an EU dimension are notifiable under the EU Merger Regulation (Council Regulation (EC) No 139/2004) and cannot close before clearance: the stand-still obligation applies, and gun-jumping carries fines. The thresholds turn on worldwide and EU-wide turnover of the undertakings concerned, and the question of whether a transaction confers control within the meaning of the Regulation. For a Chinese buyer acquiring a European target, the analysis starts with the turnover test, then with whether the acquisition of a minority stake or a joint venture structure triggers notification. Getting the control analysis wrong at the outset is a common failure mode.

The stand-still obligation is the discipline that Chinese buyers most often underestimate. From the moment the transaction acquires a notifiable character, the parties cannot implement it — no voting rights exercised, no board seats taken, no integration steps — until clearance is granted. The classic gun-jumping scenarios in the EU record include information exchange between competitors, pre-clearance integration of sales teams, and the exercise of influence through the acquired stake. For a Chinese group acquiring a European business, the integration planning that naturally starts on day one must be ring-fenced: a clean team, a clean information wall, and a documented compliance protocol until the Commission's decision arrives.

Phase I, Phase II and remedies#

The European Commission (DG COMP) reviews notifiable concentrations in a Phase I procedure, which can be extended or referred to a Phase II investigation where competition concerns arise. Phase II matters are where market definition, economic evidence and efficiency defences decide the outcome, and where remedy packages matter most: structural remedies (divestitures) and behavioural remedies (access and licensing obligations) are negotiated to resolve concerns in high-concentration markets. A representative matter involved a global semiconductor manufacturer in a EUR 12 billion cross-border acquisition that secured unconditional Phase I clearance from the Commission with coordinated global clearances; another involved a high-profile industrial joint venture where a Phase II investigation by national authorities was resolved with a behavioural remedy package.

The remedy strategy should be built before the Commission raises the concern, not after. For a Chinese buyer, the willingness to offer a divestiture or an access remedy is a commercial decision that the board should make in the deal-room planning phase, because the remedy negotiation runs on the transaction's critical path and the Commission's timetable does not wait for internal approval processes. A pre-agreed remedy mandate — the maximum divestiture the board will accept, the access terms it will grant, and the entities it will not divest — shortens the negotiation and protects the closing date.

Article 22 referrals and the expanding net#

Article 22 of the EUMR allows member states to request referral of transactions that do not meet the national thresholds, and the Commission's 2021 guidance revived the use of Article 22 to catch transactions below the turnover thresholds — a tool that has been used against deals in digital and innovative sectors where turnover does not reflect competitive significance. For a Chinese buyer, the Article 22 risk appears where the transaction is below the thresholds but affects a member state's market in a way that national authority considers significant. The assessment is not a threshold arithmetic exercise; it is a substantive competitive-significance analysis that the parties should run in the planning phase, with the same rigour as the threshold test.

The referral mechanism also works in reverse: the parties can request a referral of a multi-jurisdictional transaction to the Commission under Article 4(5) (pre-notification referral) to avoid a patchwork of national filings. For a deal that touches several EU member states, a one-stop-shop review at the Commission is usually faster and more predictable than parallel national reviews, and the referral decision should be made as part of the notification strategy, not after the national deadlines have started.

National FDI screening — the second workstream#

Regulation (EU) 2019/452 establishes an EU framework for the screening of foreign direct investments on security and public-order grounds, and nearly every member state now operates a national FDI screening regime. The regimes vary in scope, thresholds, and timing — some are mandatory for defined sectors, others are voluntary with the power to intervene — but the common thread is that a Chinese buyer's acquisition in sectors such as semiconductors, defence, energy, critical infrastructure, data, and advanced manufacturing will face scrutiny that turns on the acquirer's ownership, the target's strategic sensitivity, and the funding structure. FDI screening is not a merger-control filing; it can prohibit a transaction outright, impose conditions, or unwind a closing that happened without clearance.

The interaction between merger control and FDI screening is where cross-border deals most often fail: the merger notification runs to DG COMP, the FDI screening runs to the national authority, and the two have different timelines, different information requests, and different remedies. The transaction's closing condition must be drafted to cover both — "clearance under the EUMR and no objection under the applicable FDI regime" — and the information-sharing between the two workstreams must be managed so that the parties do not reveal more in one than the law requires. For a Chinese buyer, the FDI file is also where the ownership and funding transparency is tested: the authority will examine the ultimate beneficial owner, the source of funds, and any state-linked financing, and the file should answer those questions before they are asked.

The Foreign Subsidies Regulation — the third workstream#

The EU Foreign Subsidies Regulation (Regulation (EU) 2022/2560) introduces notification obligations for concentrations where the parties received foreign financial contributions above defined thresholds, and an ex-officio tool for other cases. The FSR is the newest and least familiar workstream, and it is the one that catches Chinese buyers off guard: financial contributions from non-EU governments — including subsidies, loans, guarantees, tax incentives, and government procurement — can trigger an FSR notification even where the transaction is not notifiable under the EUMR. Articles 10 and 21 of the FSR set out the notification thresholds and the Commission's investigative powers, and the FSR regime operates alongside, not instead of, the merger and FDI regimes.

The FSR analysis requires the parties to map their foreign financial contributions, which for a Chinese state-linked group is a significant exercise: the contribution register covers the group's borrowing, guarantees, tax benefits, equity injections, and any government-linked financing, and the thresholds are tested at the group level. The Commission's FSR investigations have already produced in-depth cases involving state-backed tender bids and acquisitions, and the enforcement trajectory shows that the FSR is being used actively, not reserved as a theoretical tool. The practical consequence for a Chinese buyer is that the FSR due diligence must start with the first term sheet, not after the merger notification is filed, because the contribution register takes time to assemble and the notification clock runs from signing.

The clearance calendar and the reverse-termination fee#

The three workstreams run on different clocks, and the transaction's clearance calendar must integrate them. The EUMR notification is filed after the transaction is agreed and the stand-still obligation applies; the FDI screening is run by the member state on its own timeline, which can extend beyond the merger review; and the FSR notification, where thresholds apply, must be filed before closing with its own review period. The calendar is built from the earliest trigger backward: the FSR contribution register starts at signing, the FDI file starts when the target's sector is identified, and the EUMR notification starts when the transaction's structure is fixed. The closing condition is drafted to require clearance or non-objection from all three, and the long-stop date must accommodate the longest realistic timeline.

The reverse-termination fee is the commercial expression of the clearance risk. A buyer that agrees a nominal fee while facing a real FSR or FDI review has mispriced the deal's execution risk; a buyer that negotiates a fee reflecting the actual probability and cost of a failed clearance has a deal that both sides can close. For Chinese buyers, the fee negotiation is also where the seller's perception of regulatory risk is tested: a seller that understands the three-track process will price the risk into the fee, while a seller that treats clearance as a formality will resist a realistic fee and may walk away late. The clearance calendar, the closing condition, and the fee are one negotiation, not three.

What we see in the field: working with Chinese buyers through EU clearance#

In our work with Chinese state-linked and private groups on EU acquisitions, the clearance sequence is the make-or-break of the deal, and the pattern of failures is consistent. The deals that close on schedule are the ones that build the three-track calendar at signing: the EUMR notification strategy, the FDI screening map of every member state with a trigger, and the FSR contribution register assembled from the group's financing records. The deals that stall are the ones that discover the FSR notification mid-process, or that treat FDI screening as a formality and learn from a national authority's information request that the acquirer's ownership and funding structure required a far longer review. For Chinese buyers, three disciplines matter most. First, map the foreign financial contributions early — the FSR register is a group-level exercise and it cannot be built in a week. Second, draft the closing condition to cover all three workstreams, with a reverse-termination fee that reflects the actual clearance risk rather than a nominal amount. Third, run the Article 22 and FDI sensitivity analysis in the deal-room planning, so that the remedy mandate and the information-sharing protocol are decided before the regulator asks. The clearance file — the three-track calendar, the contribution register, the remedy mandate — is the document that the board, the lenders, and the seller all read, and the deals that close are the ones where that file is complete before the signature.

Next steps#

If your group is acquiring or forming a JV in the EU, map the three workstreams before signing: the EUMR thresholds, the national FDI triggers, and the FSR contribution register. The clearance strategy is a deal-room discipline, not a post-signing scramble.

Request a consultation Find counsel